Analyst Ratings for Entrada Therapeutics (TRDA)
TRDA Rating Summary
TRDA Price Target Summary
- Highest: $22.00 (Oppenheimer)
- Lowest: $20.00 (H.C. Wainwright)
- Average: $21.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.00 (+69.9%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 80%
Avg. $ Target:
$21.00 (+69.9%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2024 | Oppenheimer | Hartaj Singh | New Coverage | Outperform (N/A) |
22.00 (N/A) |
13.80 (12.36) |
-10.43% | Details |
| 4/3/2023 | H.C. Wainwright » Updated 11/27/2023 |
Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
20.00 (25.00) |
14.50 (12.36) |
-14.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
